Advanced Drug Delivery Systems Market, By Type, By Application, By Carrier Type, By End User, By Geography

Description

The advanced drug delivery systems market is estimated to be valued at USD 254.44 Bn in 2024 and is expected to reach USD 375.94 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	254.44 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	5.70%	2031 Value Projection:	375.94 Bn

Figure. Advanced Drug Delivery Systems Market Share (%), By Region, 2024

Advanced Drug Delivery Systems Market - IMG1

Advanced drug delivery systems have enabled the development of novel formulations that can specifically target drugs to areas of the body for localized or sustained treatment. Nanotechnology and other engineering approaches have facilitated the creation of intelligent delivery vehicles like micelles, dendrimers, liposomes, and polymeric nanoparticles that can shield drugs from degradation and control their release. Such delivery platforms help improve the therapeutic index of many drugs by increasing their efficacy and reducing unwanted side effects. With their ability to cross biological barriers and precisely deliver therapeutic payloads, advanced drug delivery systems are revolutionizing the treatment of cancer and other serious diseases.

Market Dynamics:

The advanced drug delivery systems market is driven by the growing demand for targeted and controlled drug delivery. Increasing R&D investments by pharmaceutical companies to develop innovative formulations and the rising prevalence of chronic diseases like cancer are fueling market growth. However, high development costs and regulatory issues pose challenges to new entrants. The untapped potential of emerging economies presents an opportunity for market expansion. Additionally, the growing application scope of advanced delivery technologies like long-acting injectables could open new avenues for drug developers.

Key features of the study:

This report provides in-depth analysis of the global advanced drug delivery systems market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global advanced drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Baxter, 3M, Abbott, Datwyler Holding Inc., Evonik, Astrazeneca, Novo Nordisk A/S, Corium Innovations, Inc., PolyActiva, Teleflex Incorporated, Elixir Medical, B. Braun SE, Nemera, Epion Therapeutics, Inc., Terumo Corporation, and Flowonix Medical Inc

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global advanced drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced drug delivery systems market

Market Segmentation

Type Insights
- Oral Drug Delivery System
- Injection-Based Drug Delivery System
- Inhalation/Pulmonary Drug Delivery System
- Transdermal Drug Delivery System
- Carrier Based Drug Delivery System
- Others (Transmucosal Drug Delivery System, etc.)
Application Insights
- Cardiovascular Diseases
- Oncology
- Urology
- Ophthalmology
- Inflammatory Diseases
- Others (Infectious Diseases, etc.)
Carrier Type Insights
- Liposomes
- Nanoparticles
- Microspheres
- Monoclonal Antibodies
End User Insights
- Hospitals
- Specialty Clinics
- Others (Research Institutes, etc.)
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Baxter
- 3M
- Abbott
- Datwyler Holding Inc.
- Evonik
- Astrazeneca
- Novo Nordisk A/S
- Corium Innovations, Inc.
- PolyActiva
- Teleflex Incorporated
- Elixir Medical
- Braun SE
- Nemera
- Epion Therapeutics, Inc.
- Terumo Corporation
- Flowonix Medical Inc

Product Code: CMI5243

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Advanced Drug Delivery Systems Market, By Type
- Advanced Drug Delivery Systems Market, By Application
- Advanced Drug Delivery Systems Market, By Carrier Type
- Advanced Drug Delivery Systems Market, By End User
- Advanced Drug Delivery Systems Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Advanced Drug Delivery Systems Market, By Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Injection-Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inhalation/Pulmonary Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Transdermal Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Carrier Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Transmucosal Drug Delivery System, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Advanced Drug Delivery Systems Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inflammatory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Infectious Diseases, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Advanced Drug Delivery Systems Market, By Carrier Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nanoparticles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microspheres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Advanced Drug Delivery Systems Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Advanced Drug Delivery Systems Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany

oU.K.

Spain
France
Italy
Russia
Rest of Europe

Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Baxter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Datwyler Holding Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evonik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astrazeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novo Nordisk A/S
Corium Innovations, Inc.
PolyActiva
Teleflex Incorporated
Elixir Medical
Braun SE
Nemera
Epion Therapeutics, Inc.
Terumo Corporation
Flowonix Medical Inc

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us